Dr David Farren, chair of BMA’s Northern Ireland consultants committee, said: “No doctor wants to take strike action.

“However, there is a palpable sense of anger among all secondary care doctors at years of significant pay erosion in return for trying to deliver care in an overstretched health system.”

Dr Leanne Davison, chair of BMA’s Northern Ireland SAS committee, said the health service can “no longer run on the goodwill of front-line staff”.

“Doctors are choosing to leave the health service or to reduce their contracted hours due to continued pay erosion and we can see the outworkings of this in services having to close due to staffing shortages.

“Those with the power to change this have so far chosen not to, which has forced hospital doctors into the unacceptable position of taking strike action in order to be heard.”

The health minister said to go beyond the 3.5% as recommended by the independent pay review recommendation would have “significant repercussions for nurses, teachers, police officers and indeed the entire public sector workforce”.

“I reiterate my commitment to ensuring HSC colleagues receive their recommended 26/27 pay uplifts, despite the unprecedented shortfall as indicated in my draft budget,” he said.

“There is simply no scope for pay awards beyond the recommendations of the review bodies in 26/27.”



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Más californianos están muriendo por el frío. Gran parte son personas mayores sin techo

SACRAMENTO, California — Un número creciente de personas —muchas de ellas mayores y sin hogar— están muriendo de frío durante el invierno. La hipotermia causada por la exposición a bajas

Heart rhythm disorder traced to bacterium lurking in our gums

Tempted to skip the floss? Your heart might thank you if you don’t. A new study from Hiroshima University (HU) finds that the gum disease bacterium Porphyromonas gingivalis (P. gingivalis)

Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs

Arthur Allen FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the